Advanced Oncotherapy PLC Holding(s) in Company (9800F)

TIDMAVO TIDMAV.

RNS Number : 9800F

Advanced Oncotherapy PLC

23 May 2017

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                       Advanced Oncotherapy plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------------  ---------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
----------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
--------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
--------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
--------------------------------------------------------------------------------------------------------- 
 An event changing the breakdown of voting rights 
  : 
--------------------------------------------------------------------------------------------------------- 
 Other (please                                                   CHANGE TO THE NUMBER OF VOTING RIGHTS 
  specify):                                                                    IN ISSUE 
-----------------------------------------------------------  -------------------------------------------- 
 3. Full name of person(s)                                      Aviva plc & its subsidiaries 
  subject to the 
  notification obligation: 
  (iii) 
-------------------------------------------------------------  -------------------------------------------- 
 4. Full name of shareholder(s)                                      Registered Holder: 
  (if different from 3.):(iv) 
                                                                      Available on Request 7,068* 
 
                                                                      Chase (GA Group) Nominees 
                                                                      Limited 1,950,852* 
 
                                                                      HSBC Global Custody Nominee 
                                                                      (UK) Limited 
                                                                      328,573* 
 
                                                                      *denotes direct interest 
-------------------------------------------------------------  -------------------------------------------- 
 5. Date of the transaction                                     19 May 2017 
  and date on 
  which the threshold is crossed 
  or 
  reached: (v) 
-------------------------------------------------------------  -------------------------------------------- 
 6. Date on which issuer notified:                              22 May 2017 
-------------------------------------------------------------  -------------------------------------------- 
 7. Threshold(s) that is/are                                    3% to <3% Change at Direct 
  crossed or                                                     Interest Level 
  reached: (vi, vii) 
-------------------------------------------------------------  -------------------------------------------- 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous              Resulting situation after 
  of              to the triggering               the triggering transaction 
  shares          transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  ------------------------------  -------------------------------------------------------------- 
                 Number          Number          Number      Number of                    % of voting 
                  of              of              of          voting                       rights (x) 
                  Shares          Voting          shares      rights 
                                  Rights 
--------------  --------------  --------------  ----------  ---------------------------  --------------------- 
                                                 Direct      Direct        Indirect       Direct   Indirect 
                                                              (xi)          (xii) 
--------------   -------------   -------------  ----------  ------------  -------------  -------  ------------ 
 Ordinary 
  Shares GBP 
  0.25 
                 2,296,493       2,296,493                                 ** Not                  ** Not 
  GB00BD6SX109   *               *               2,286,493   2,286,493     disclosable    2.98%    disclosable 
                --------------  --------------  ----------  ------------  -------------  -------  ------------ 
 
 
   * Includes Right to Recall Loaned Shares (10,000) 
-------------------------------------------------------------------------------------------------------------- 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------- 
 Type of          Expiration      Exercise/      Number of voting          % of voting 
 financial         date           Conversion      rights that               rights 
 instrument        (xiii)         Period (xiv)    may be 
                                                  acquired if 
                                                  the 
                                                  instrument 
                                                  is 
                                                  exercised/ 
                                                  converted. 
---------------  --------------  -------------  ------------------------  ------------------------------------ 
 RIGHT TO                                        10,000* 
  RECALL 
  LOANED SHARES   N/A             N/A             *Direct Interest                        0.01% 
---------------  --------------  -------------  ------------------------  ------------------------------------ 
 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting 
  instrument          price      date         Conversion    rights instrument    rights (xix, 
                                 (xvii)       period        refers to            xx) 
                                              (xviii) 
------------------  ---------  -----------  ------------  -------------------  ---------------- 
                                                                                Nominal   Delta 
------------------  ---------  -----------  ------------  -------------------  --------  ------ 
 
 
 
 Total (A+B+C) 
------------------------------------------------------ 
 Number of voting rights   Percentage of voting rights 
------------------------  ---------------------------- 
 2,296,493                 2.99% 
------------------------  ---------------------------- 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
---------------------------------------------------------------------- 
      The voting rights are managed and controlled by Aviva 
       Investors Global Services Limited and Friends Provident 
       International Limited, with the following chain of controlled 
       undertakings:- 
 
       Aviva Investors Global Services Limited: 
        *    Aviva plc (Parent Company) 
 
 
        *    Aviva Group Holdings Limited (wholly owned subsidiary 
             of Aviva plc) 
 
 
        *    Aviva Investors Holdings Limited (wholly owned 
             subsidiary of Aviva Group Holdings Limited) 
 
 
        *    Aviva Investors Global Services Limited (wholly owned 
             subsidiary of Aviva Investors Holdings Limited) 
 
 
 
       Friends Provident International Limited: 
        *    Aviva plc (Parent Company) 
 
 
        *    Aviva Group Holdings Limited (wholly owned subsidiary 
             of Aviva plc) 
 
 
        *    Friends Provident International Limited (wholly owned 
             subsidiary of Aviva Group Holdings Limited) 
 
 Proxy Voting: 
---------------------------------------------------------------------- 
 10. Name of the proxy holder:                      See Section 4 
-------------------------------------------------  ------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------------------  ------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------------------  ------------------- 
 
 
                                  Figures are based on a total 
  13. Additional information:      number of voting rights of 
                                   76,609,194 as per the Company's 
                                   'Conversion of Convertible 

                                   Loan Notes' announcement 
                                   of 
                                   16 May 2017. 
 
                                   ** Although not reportable, 
                                   as per DTR5.1.5,the non-disclosable 
                                   (indirect) position is currently 
                                   865,438 shares, and is included 
                                   here in the interests of 
                                   transparency. 
-------------------------------  ------------------------------------- 
 14. Contact name:                Neil Whittaker, Aviva plc 
-------------------------------  ------------------------------------- 
 15. Contact telephone number:    01603 684420 
-------------------------------  ------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUOVRRBOAVUAR

(END) Dow Jones Newswires

May 23, 2017 07:01 ET (11:01 GMT)